During the past decade, Schmerzklinik Kiel conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Schmerzklinik Kiel" #1 sponsor was "Allergan" with 2 trials, followed by "Amgen" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Leiden University Medical Center" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schmerzklinik Kiel" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Canisius-Wilhelmina Hospital" with 1 trials as a collaborator, "Centre Hospitalier Régional de la Citadelle" with 1 trials as a collaborator, "Erasmus Medical Center" with 1 trials as a collaborator and "Maastricht University Medical Center" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Schmerzklinik Kiel" are "Migraine" (3 trials), "Chronic Cluster Headache" (1 trials), "Migraine Disorders" (1 trials), "Migraine With Aura" (1 trials) and "Myofascial Pain Syndromes" (1 trials). Many other conditions were trialed in "Schmerzklinik Kiel" in a lesser frequency.

Most popular intervention types in "Schmerzklinik Kiel" are "Drug" (4 trials), "Device" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials), "Erenumab Dose 3" (2 trials), "Placebo" (2 trials) and "AGN-214868" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schmerzklinik Kiel" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Schmerzklinik Kiel". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Schmerzklinik Kiel, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Schmerzklinik Kiel, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".